Results 151 to 160 of about 24,950 (282)

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. [PDF]

Medicina (Kaunas)
Roidos C, Sountoulides P, Papathanasiou K, Symeonidis A, Mykoniatis I.   +4 more
europepmc   +1 more source

Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint [PDF]

, 2016
Edwin S. Epstein
openalex   +1 more source

222 Pharmacovigilance Analysis of Reports of Sexual Dysfunction Associated with Finasteride Use: Implications for the Post-Finasteride Syndrome

Introduction Finasteride, a 5α-reductase inhibitor, is used in the management of androgenetic alopecia and benign prostatic hyperplasia (BPH). There is growing attention to the post-finasteride syndrome, a constellation of adverse events associated with ...
Herzog P, Basaria S, Zorn KC, Chughtai B, Nguyen D, Elterman DS, Bhojani N, Trinh Q, Labban M, Cone EB   +9 more
core  

Autologous Micrograft Technology (AMT) and Finasteride for the Management of Androgenic Alopecia - A Systematic Review and Meta-Analysis of Their Efficacy and Safety. [PDF]

Dermatol Pract Concept
Ellerby A, Knudsen R.
europepmc   +1 more source

Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Disease

, 2015
Ashraful Hoque, Song Yao, Cathee Till, Alan R. Kristal, Phyllis J. Goodman, Ann W. Hsing, Catherine M. Tangen, Elizabeth A. Platz, Frank Z. Stanczyk, Juergen Reichardt, Adrie vanBokhoven, Marian L. Neuhouser, Regina M. Santella, William D. Figg, Douglas K. Price, Howard L. Parnes, Scott M. Lippman, Christine B. Ambrosone, Ian M. Thompson   +18 more
openalex   +2 more sources

Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study. [PDF]

J Clin Med
Jędrzejczyk P, Ząbkowski T, Ratajski J, Ciechan K, Kaminski TW, Uciechowski P, Syryło T.   +6 more
europepmc   +1 more source

Rice bran oil ameliorates the symptoms of benign prostatic hyperplasia in male Wistar rats. [PDF]

Avicenna J Phytomed
Miah MA, Sathi MA, Hasib MG, Rahman M, Mahmud N, Shill MC, Reza HM, Hossain M, Rahman MM, Mostaid MS.   +9 more
europepmc   +1 more source

Do finasteride and bicalutamide affect blood glucose levels in diabetics?

Tripdatabase
openalex   +1 more source

017 Pharmacovigilance Analysis of Reports of Sexual Dysfunction Associated with Finasteride Use: Implications for the Post-Finasteride Syndrome

Introduction Finasteride, a 5α-reductase inhibitor, is used in the management of androgenetic alopecia and benign prostatic hyperplasia (BPH). There is growing attention to the post-finasteride syndrome, a constellation of adverse events associated with ...
Chughtai B., Bhojani N., Basaria S., Herzog P., Labban M., Cone E.B., Trinh Q., Nguyen D., Zorn K.C., Elterman D.S.   +9 more
core  

Male Androgenetic Alopecia : Response To Finasteride

, 2004
Androgenetic alopecia (AGA) is one of the most common causes of hair loss in genetically predisposed men and women. We studied the therapeutic efficacy and safety of oral finasteride in male patients with AGA. A total of 40 male AGA patients, 18-35 years
Reddy B. S. N, Thakkar Suruchi
core